Renishaw announces CE Mark and European launch of the neurolocate™ frameless patient registration system

Renishaw is pleased to announce the launch of the neurolocate™ patient registration system in countries that recognise the CE (Conformité Européene) mark.

projít na článek

neurolocate™ registration module

Frameless patient registration module for use with the neuromate® stereotactic robot.

projít na článek

neuromate® frameless Gen II robot installation and first deep brain stimulation (DBS) performed in the USA at The Ohio State University Wexner Medical Center

Renishaw is pleased to announce that a neuromate frameless Gen II stereotactic robotic system has been installed at the Department of Neurological Surgery at The Ohio State University Wexner Medical Center in Columbus, Ohio.

projít na článek

Renishaw announces completion of the main part of a multi-centre clinical trial

Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine

projít na článek

Renishaw launches Raman system for forensic analysis

Renishaw today announced the launch of the inVia™ InSpect, a new version of its bestselling inVia confocal Raman microscope, optimised for use in forensic laboratories for trace chemical analysis.

projít na článek

Renishaw to launch powerful new software

Now, with Renishaw’s new WiRE 4 software, inVia users can produce high definition chemical images from very large Raman datasets.

projít na článek